SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

2 European Hospitals Begin Certification to Implant SynCardia's Total Artificial Heart

Ankara University in Turkey and Ljubljana University Medical Center in Slovenia Become 59th and 60th Centers to Begin Certification

 

60 hospitals worldwide have begun certification to implant the SynCardia temporary Total Artificial Heart. 60 hospitals worldwide have begun certification to implant the SynCardia temporary Total Artificial Heart.

TUCSON, Ariz. – Dec. 7, 2010 – SynCardia Systems, Inc. announced today that the surgical teams from Ljubljana University Medical Center in Slovenia and Ankara University in Turkey have completed the first phase of certification to implant the SynCardia temporary Total Artificial Heart in Paris. The two hospitals are the 59th and 60th transplant centers worldwide to begin the four-phase certification process.

Ljubljana University Medical Center (Slovenia)
Led by: Drs. Ivan Knezevic and Matija Jelenc
Ljubljana is one of the largest hospitals in central Europe and the first hospital in Slovenia to begin certification for the Total Artificial Heart. In 2009, Ljubljana performed 16 heart transplants. In Slovenia, there are approximately 30,000 people suffering from heart failure, with an additional 3,000 new cases diagnosed annually.

In November 2007, Ljubljana performed Slovenia's first implant of a mechanical circulatory support (MCS) device. The hospital projects performing approximately 15 MCS surgeries annually, including the Total Artificial Heart.

Ankara University (Turkey)
Led by: Prof. Ahmet Ruchan Akar, M.D. and Prof. Sadik Eryilmaz, M.D.
Ankara University performs approximately 1,000 open heart operations annually. The Cardiovascular Department consists of four operating rooms and 84 patient beds. The department staff includes 9 staff surgeons and 4 fellow surgeons.

Ankara University performed Turkey's first artificial heart implant on Feb. 27, 1988, when it implanted the Symbion Jarvik 7 artificial heart, the predecessor to the SynCardia temporary Total Artificial Heart, as a bridge to transplant.

Around the world, there are currently 33 SynCardia Certified Centers, including 18 in Europe. An additional 18 European hospitals and 10 U.S. hospitals are currently undergoing certification. SynCardia Certified Centers are located in Germany, Italy, France, Australia, Russia, Austria, Turkey, Sweden, Canada and the U.S.

###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

Search offcanvas